Market Summary
USD70.96+2.93
Market Closed4.31%
MMSI Stock Price
MMSI RSI Chart
MMSI Valuation
MMSI Price/Sales (Trailing)
MMSI Profitability
MMSI Fundamentals
MMSI Revenue
MMSI Earnings
Price Action
52 Week Range
50.4675.25
(Low)(High)
Last 7 days
2.0%
Last 30 days
-4.0%
Last 90 days
-4.5%
Trailing 12 Months
8.2%
MMSI Financial Health
MMSI Investor Care
Peers (Alternatives to Merit Medical Systems)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 104.1B | 18.4B | 2.26% | 8.00% | 44.16 | 5.64 | 7.84% | 18.25% |
ISRG | 84.2B | 6.2B | -4.47% | -13.27% | 63.66 | 13.53 | 8.97% | -22.43% |
BSX | 69.1B | 12.7B | 0.59% | 12.45% | 99.06 | 5.45 | 6.68% | -32.95% |
BDX | 67.4B | 19.0B | -5.16% | -6.78% | 41.86 | 3.55 | -0.43% | -8.78% |
EW | 49.8B | 5.4B | 2.41% | -25.12% | 32.74 | 9.26 | 2.86% | 1.25% |
| MID-CAP | ||||||||
SWAV | 7.2T | 489.7M | 9.34% | 31.15% | 82.2K | 16.8K | 106.51% | 2464.23% |
PEN | 10.2B | 847.1M | -3.64% | 34.52% | -5.1K | 12.05 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.19 | 5.09 | 6.76% | 24.45% |
IRTC | 3.5B | 410.9M | 4.51% | -3.13% | -29.82 | 8.43 | 27.29% | -14.60% |
TNDM | 2.7B | 801.2M | 1.13% | -58.87% | -28.25 | 3.34 | 14.00% | -707.69% |
| SMALL-CAP | ||||||||
SILK | 1.7B | 138.6M | -15.68% | 29.18% | -30.43 | 12.07 | 36.62% | -10.44% |
ATEC | 1.6B | 350.9M | 10.38% | 49.06% | -10.84 | 4.7 | 44.26% | -5.42% |
AVNS | 1.3B | 820.0M | -8.35% | -12.22% | 25.89 | 1.59 | 10.13% | 701.59% |
CSII | 828.4M | 239.8M | 0.30% | 1.49% | -21.88 | 3.45 | -4.74% | -31.15% |
Financials for Merit Medical Systems
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.3% | 1,151 | 1,136 | 1,116 | 1,101 | 1,075 |
| Gross Profit | 1.1% | 519 | 513 | 505 | 494 | 485 |
| Operating Expenses | -0.6% | 432 | 434 | 429 | 432 | 424 |
| S&GA Expenses | 2.0% | 343 | 336 | 333 | 339 | 336 |
| EBITDA | 6.6% | 171 | 160 | 156 | 143 | - |
| EBITDA Margin | 5.3% | 0.15* | 0.14* | 0.14* | - | - |
| Earnings Before Taxes | 13.7% | 83.00 | 73.00 | 69.00 | 55.00 | 54.00 |
| EBT Margin | 12.3% | 0.07* | 0.06* | 0.06* | - | - |
| Interest Expenses | 19.9% | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Net Income | 20.7% | 75.00 | 62.00 | 58.00 | 48.00 | 48.00 |
| Net Income Margin | 19.2% | 0.06* | 0.05* | 0.05* | - | - |
| Free Cahsflow | -24.1% | 69.00 | 91.00 | 90.00 | 93.00 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | 1.9% | 1,664 | 1,633 | 1,632 | 1,630 | 1,648 |
| Current Assets | 5.8% | 529 | 500 | 493 | 478 | 482 |
| Cash Equivalents | 13.5% | 58.00 | 51.00 | 63.00 | 54.00 | 68.00 |
| Inventory | 7.8% | 266 | 247 | 233 | 231 | 222 |
| Net PPE | 1.8% | 383 | 376 | 371 | 372 | 372 |
| Goodwill | 0.5% | 360 | 358 | 360 | 361 | 362 |
| Liabilities | -4.5% | 520 | 544 | 558 | 573 | 608 |
| Current Liabilities | 3.6% | 221 | 213 | 196 | 204 | 236 |
| Long Term Debt | -11.9% | 217 | 246 | 252 | 243 | - |
| LT Debt, Current | 0% | 11.00 | 11.00 | 10.00 | 9.00 | 8.00 |
| LT Debt, Non Current | -9.1% | 187 | 205 | 236 | 243 | 234 |
| Shareholder's Equity | 5.1% | 1,144 | 1,089 | 1,073 | 1,057 | 1,040 |
| Retained Earnings | 7.5% | 481 | 447 | 432 | 417 | 406 |
| Accumulated Depreciation | 1.1% | 303 | 300 | 294 | 288 | 281 |
| Shares Outstanding | 0.7% | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -13.5% | 114 | 132 | 122 | 124 | 147 |
| Share Based Compensation | -0.8% | 18.00 | 18.00 | 18.00 | 17.00 | 16.00 |
| Cashflow From Investing | -5.0% | -57.40 | -54.67 | -45.20 | -40.68 | -37.16 |
| Cashflow From Financing | 30.7% | -60.26 | -86.98 | -77.80 | -86.43 | -98.43 |
Risks for MMSI
What is the probability of a big loss on MMSI?
68.8%
Probability that Merit Medical Systems stock will be more than 20% underwater in next one year
21.9%
Probability that Merit Medical Systems stock will be more than 30% underwater in next one year.
19.6%
Probability that Merit Medical Systems stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does MMSI drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Merit Medical Systems was unfortunately bought at previous high price.
Drawdowns
Returns for MMSI
Cumulative Returns on MMSI
18.6%
10-Year Cumulative Returns
21.3%
7-Year Cumulative Returns
8.6%
5-Year Cumulative Returns
26.4%
3-Year Cumulative Returns
What are the long-term rolling returns for MMSI?
FIve years rolling returns for Merit Medical Systems.
Annualized Returns
Which funds bought or sold MMSI recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -19.55 | 24,243 | 4,333,240 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -92.25 | -30,132,000 | 3,232,000 | 0.02% |
2023-02-28 | Voya Investment Management LLC | reduced | -8.77 | 951,732 | 7,746,730 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 17.46 | 392,000 | 1,230,000 | 0.01% |
2023-02-21 | KB FINANCIAL PARTNERS, LLC | new | - | 3,000 | 3,000 | -% |
2023-02-21 | MACQUARIE GROUP LTD | added | 2.62 | 22,600,000 | 102,852,000 | 0.12% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -83.84 | -36,607 | 9,393 | -% |
2023-02-17 | TRUIST FINANCIAL CORP | new | - | 201,337 | 201,337 | -% |
2023-02-16 | GHP Investment Advisors, Inc. | unchanged | - | 3,124 | 14,124 | -% |
2023-02-16 | MAVERICK CAPITAL LTD | added | 10.02 | 108,319 | 396,319 | 0.01% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Merit Medical Systems News
Schedule 13G FIlings of Merit Medical Systems
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 15, 2023 | arrowmark colorado holdings llc | 4.42% | 2,517,226 | SC 13G/A | |
| Feb 09, 2023 | william blair investment management, llc | 6.6% | 3,729,980 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 11.99% | 6,824,344 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 17.0% | 9,670,688 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 17.0% | 9,670,688 | SC 13G/A | |
| Feb 14, 2022 | arrowmark colorado holdings llc | 5.51% | 3,111,000 | SC 13G/A | |
| Feb 10, 2022 | vanguard group inc | 10.16% | 5,737,781 | SC 13G/A | |
| Feb 10, 2022 | william blair investment management, llc | 5.9% | 3,357,638 | SC 13G/A | |
| Jan 27, 2022 | blackrock inc. | 14.8% | 8,334,516 | SC 13G/A | |
| Jan 25, 2022 | blackrock inc. | 14.8% | 8,334,516 | SC 13G/A |
MMSI Fair Value
Recent SEC filings of Merit Medical Systems
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 16, 2023 | 4 | Insider Trading | |
| Mar 15, 2023 | 4 | Insider Trading | |
| Mar 14, 2023 | 4 | Insider Trading | |
| Mar 10, 2023 | 4 | Insider Trading | |
| Mar 08, 2023 | 4 | Insider Trading | |
| Mar 07, 2023 | 4 | Insider Trading | |
| Mar 03, 2023 | 4 | Insider Trading | |
| Mar 02, 2023 | 4 | Insider Trading | |
| Mar 02, 2023 | 4 | Insider Trading | |
| Mar 02, 2023 | 4 | Insider Trading |
Latest Insider Trading transactions for MMSI
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-14 | Voigt Michel James | sold | -136,620 | 68.31 | -2,000 | chief human resources officer |
2023-03-13 | Lloyd Brian G. | gifted | - | - | -1,450 | chief legal officer, secretary |
2023-03-08 | Ward Lynne | acquired | 68,920 | 34.46 | 2,000 | - |
2023-03-08 | Ward Lynne | sold | -772,789 | 66.706 | -11,585 | - |
2023-03-07 | ANDERSON A SCOTT | gifted | - | - | -3,000 | - |
2023-03-06 | ANDERSON A SCOTT | sold | -1,001,160 | 66.744 | -15,000 | - |
2023-03-06 | ANDERSON A SCOTT | acquired | 438,000 | 29.2 | 15,000 | - |
2023-03-03 | Parra Raul Jr. | sold | -71,610 | 70.00 | -1,023 | cfo and treasurer |
2023-03-02 | LAMPROPOULOS FRED P | sold | -1,339,620 | 69.859 | -19,176 | president and ceo |
2023-03-02 | Parra Raul Jr. | acquired | 226,260 | 37.71 | 6,000 | cfo and treasurer |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
MMSI Income Statement
2022-12-31CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Income Statement [Abstract] | |||
| Net sales | $ 1,150,981 | $ 1,074,751 | $ 963,875 |
| Cost of sales | 631,882 | 589,418 | 562,698 |
| Gross profit | 519,099 | 485,333 | 401,177 |
| Operating expenses: | |||
| Selling, general and administrative | 342,525 | 335,690 | 297,724 |
| Research and development | 75,510 | 71,247 | 57,537 |
| Legal settlement | 10,036 | 18,684 | |
| Impairment charges | 2,219 | 4,283 | 36,504 |
| Contingent consideration expense (benefit) | 4,611 | 3,161 | (7,960) |
| Acquired in-process research and development | 6,671 | 250 | |
| Total operating expenses | 431,536 | 424,417 | 402,739 |
| Income (loss) from operations | 87,563 | 60,916 | (1,562) |
| Other income (expense): | |||
| Interest income | 439 | 769 | 604 |
| Interest expense | (6,339) | (5,261) | (9,994) |
| Other income (expense) - net | 966 | (2,507) | (2,279) |
| Total other expense - net | (4,934) | (6,999) | (11,669) |
| Income (loss) before income taxes | 82,629 | 53,917 | (13,231) |
| Income tax expense (benefit) | 8,113 | 5,463 | (3,388) |
| Net income (loss) | $ 74,516 | $ 48,454 | $ (9,843) |
| Earnings (loss) per common share | |||
| Basic (in dollars per share) | $ 1.31 | $ 0.86 | $ (0.18) |
| Diluted (in dollars per share) | $ 1.29 | $ 0.84 | $ (0.18) |
| Weighted average shares outstanding | |||
| Basic (in shares) | 56,806 | 56,145 | 55,434 |
| Diluted (in shares) | 57,671 | 57,359 | 55,434 |
MMSI Balance Sheet
2022-12-31CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 58,408 | $ 67,750 |
| Trade receivables - net of allowance for credit losses - 2022 - $8,423 and 2021 - $6,767 | 164,677 | 152,301 |
| Other receivables | 12,992 | 17,763 |
| Inventories | 265,991 | 221,922 |
| Prepaid expenses and other current assets | 22,324 | 16,149 |
| Prepaid income taxes | 3,913 | 3,550 |
| Income tax refund receivables | 779 | 2,777 |
| Total current assets | 529,084 | 482,212 |
| Property and equipment: | ||
| Land and land improvements | 25,940 | 25,287 |
| Buildings | 189,148 | 190,044 |
| Manufacturing equipment | 299,089 | 277,976 |
| Furniture and fixtures | 61,128 | 61,446 |
| Leasehold improvements | 49,673 | 46,341 |
| Construction-in-progress | 61,269 | 51,182 |
| Total property and equipment | 686,247 | 652,276 |
| Less accumulated depreciation | (303,271) | (280,618) |
| Property and equipment - net | 382,976 | 371,658 |
| Other assets: | ||
| Goodwill | 359,821 | 361,741 |
| Deferred income tax assets | 6,599 | 6,080 |
| Right-of-use operating lease assets | 65,262 | 65,913 |
| Other assets | 44,352 | 41,421 |
| Total other assets | 751,906 | 794,424 |
| Total assets | 1,663,966 | 1,648,294 |
| Current liabilities: | ||
| Trade payables | 68,504 | 55,624 |
| Accrued expenses | 123,189 | 159,014 |
| Current portion of long-term debt | 11,250 | 8,438 |
| Short-term operating lease liabilities | 11,005 | 10,668 |
| Income taxes payable | 6,697 | 2,536 |
| Total current liabilities | 220,645 | 236,280 |
| Long-term debt | 186,759 | 234,397 |
| Deferred income tax liabilities | 18,462 | 31,503 |
| Long-term income taxes payable | 347 | 347 |
| Liabilities related to unrecognized tax benefits | 1,912 | 932 |
| Deferred compensation payable | 15,264 | 18,111 |
| Deferred credits | 1,708 | 1,815 |
| Long-term operating lease liabilities | 59,736 | 61,526 |
| Other long-term obligations | 14,736 | 23,584 |
| Total liabilities | 519,569 | 608,495 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Preferred stock - 5,000 shares authorized as of December 31, 2022 and December 31, 2021; no shares issued | 0 | 0 |
| Common stock, no par value; 100,000 shares authorized; issued and outstanding as of December 31, 2022 - 57,306 and December 31, 2021 - 56,570 | 675,174 | 641,533 |
| Retained earnings | 480,773 | 406,257 |
| Accumulated other comprehensive loss | (11,550) | (7,991) |
| Total stockholders' equity | 1,144,397 | 1,039,799 |
| Total liabilities and stockholders' equity | 1,663,966 | 1,648,294 |
| Developed technology | ||
| Other assets: | ||
| Intangible assets | 237,522 | 276,833 |
| Other | ||
| Other assets: | ||
| Intangible assets | $ 38,350 | $ 42,436 |